Bexitrol F MDPI 50 mcg+500 mcg is a combination dry powder inhalation therapy containing Salmeterol and Fluticasone Propionate, two well-established agents used in the long-term management of chronic respiratory diseases. This formulation is designed for maintenance treatment and helps achieve better control of symptoms by addressing both bronchoconstriction and underlying airway inflammation.

The MDPI (Metered Dose Powder Inhaler) system ensures accurate dose delivery directly to the lungs, improving therapeutic effectiveness while minimizing systemic exposure. Bexitrol F MDPI is not intended for immediate relief of acute bronchospasm but is used regularly to maintain long-term control of asthma and chronic obstructive pulmonary disease (COPD).

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Long-acting beta-2 agonist (LABA) + Inhaled corticosteroid (ICS)

Indications

Bexitrol F MDPI 50 mcg+500 mcg is indicated for:

• Long-term management of bronchial asthma in patients not adequately controlled on inhaled corticosteroids alone

• Maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema

• Prevention of asthma symptoms such as wheezing, breathlessness, chest tightness, and cough

This combination therapy is particularly beneficial for patients with moderate to severe persistent asthma or COPD requiring both bronchodilation and anti-inflammatory control.

Pharmacology

Salmeterol is a long-acting selective beta-2 adrenergic receptor agonist. It works by relaxing bronchial smooth muscles, leading to prolonged bronchodilation and improved airflow. Its long duration of action helps prevent day- and night-time respiratory symptoms.

Fluticasone Propionate is a potent inhaled corticosteroid that reduces airway inflammation by inhibiting multiple inflammatory mediators, decreasing mucosal edema, and suppressing inflammatory cell activity. This helps prevent asthma exacerbations and improves overall lung function.

Together, these agents provide complementary actions, resulting in improved symptom control, reduced frequency of exacerbations, and better quality of life.

Dosage and Administration

Bexitrol F MDPI is for inhalation use only.

• The usual dose is one inhalation twice daily or as prescribed by a physician

• Patients should use the inhaler regularly for optimal benefit

• The inhaler should be used at the same times each day

After inhalation, patients are advised to rinse their mouth with water and spit it out to reduce the risk of oral candidiasis.

Contraindications

Bexitrol F MDPI is contraindicated in:

• Patients with known hypersensitivity to Salmeterol, Fluticasone Propionate, or any component of the formulation

• Acute asthma attacks or status asthmaticus requiring rapid-acting bronchodilators

Side Effects

Commonly reported side effects may include:

• Throat irritation or hoarseness

• Headache

• Cough

• Oral fungal infections

• Palpitations or tremor (rare)

Most side effects are mild and manageable with proper inhaler technique.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Not intended for relief of acute bronchospasm

• Use with caution in patients with cardiovascular disorders, diabetes, or thyroid disease

• Do not discontinue abruptly without medical advice

• Monitor for signs of infection with long-term corticosteroid use

Pregnancy and Lactation

Bexitrol F MDPI should be used during pregnancy and lactation only if clearly needed and prescribed by a healthcare professional after assessing potential benefits and risks.

Storage Conditions

Store below 30°C in a dry place. Protect from moisture and direct sunlight. Keep out of reach of children.

Conclusion

Bexitrol F MDPI 50 mcg+500 mcg offers a reliable and effective maintenance therapy for patients with asthma and COPD. By combining long-acting bronchodilation with potent anti-inflammatory action, it helps achieve sustained symptom control, reduces exacerbations, and supports improved respiratory health when used regularly as prescribed.